×
About 37,168 results

ALLMedicine™ Pulmonary Hypertension Center

Research & Reviews  18,051 results

Recent advances in the management of pulmonary arterial hypertension: lessons from the ...
https://doi.org/10.1080/17476348.2021.1878027
Expert Review of Respiratory Medicine; Escribano Subías P, Aurtenetxe Pérez A et. al.

Jan 21st, 2021 - The 6th World Symposium of Pulmonary Hypertension (6th WSPH) brought to the forefront for the first time the value of earlier, aggressive management with an upfront oral combination in patients with pulmonary arterial hypertension (PAH) of low or ...

Comparison of 68Ga-FAPI imaging and cardiac magnetic resonance in detection of myocardi...
https://doi.org/10.1007/s12350-020-02517-2 10.1007/s12350-020-02315-w 10.1007/s12350-020-02407-7 10.1161/CIRCULATIONAHA.118.035326 10.1016/j.jcmg.2019.06.030 10.1007/s00330-016-4585-y
Journal of Nuclear Cardiology : Official Publication of T... Xing HQ, Gong JN et. al.

Jan 21st, 2021 - Comparison of 68Ga-FAPI imaging and cardiac magnetic resonance in detection of myocardial fibrosis in a patient with chronic thromboembolic pulmonary hypertension.|2021|Xing HQ,Gong JN,Chen BX,Guo XJ,Yang YH,|

Bevacizumab combined with pemetrexed successfully treated lung adenocarcinoma complicat...
https://doi.org/10.21037/apm-20-2220
Annals of Palliative Medicine; Lu L, Wang Z et. al.

Jan 21st, 2021 - Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare but severe pulmonary complication of malignant tumors. It is characterized by the presence of multiple microscopic tumor emboli attached to the endothelium of small pulmonary arteries and...

The prevalence and clinical outcome of supraventricular tachycardia in different etiolo...
https://doi.org/10.1371/journal.pone.0245752
PloS One; Fingrova Z, Ambroz D et. al.

Jan 20th, 2021 - Patients with pulmonary hypertension (PH) frequently suffer from supraventricular tachycardias (SVT). The main purpose of our study was to identify the cumulative incidence of SVT in patients with different etiologies of PH. The secondary objectiv...

see more →

Guidelines  59 results

Under Pressure: An Update on Pulmonary Hypertension
https://www.the-rheumatologist.org/article/under-pressure-an-update-on-pulmonary-hypertension/
The Rheumatologist; Liebowitz J.

Nov 8th, 2020 - In patients with connective tissue diseases, such as systemic sclerosis (SSc), pulmonary hypertension (PH) remains one of the leading causes of morbidity and mortality. In her lecture on Friday, Nov. 6, Pulmonary Hypertension: An Update, Mardi Gom...

Canadian Cardiovascular Society/Canadian Thoracic Society Position Statement on Pulmona...
https://doi.org/10.1016/j.cjca.2019.11.041
The Canadian Journal of Cardiology; Hirani N, Brunner NW et. al.

Jul 19th, 2020 - The landscape of pulmonary hypertension (PH) has changed significantly since the last Canadian Cardiovascular Society/Canadian Thoracic Society position statement in 2005. Since then, advances in our understanding of the pathophysiology of PH and ...

2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary ...
https://doi.org/10.1016/j.healun.2019.06.022
The Journal of Heart and Lung Transplantation : the Offic... Hansmann G, Koestenberger M et. al.

Sep 9th, 2019 - The European Pediatric Pulmonary Vascular Disease Network is a registered, non-profit organization that strives to define and develop effective, innovative diagnostic methods and treatment options in all forms of pediatric pulmonary hypertensive v...

Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017).
https://doi.org/10.1253/circj.CJ-66-0158
Circulation Journal : Official Journal of the Japanese Ci... Fukuda K, Date H et. al.

Mar 11th, 2019 - Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017).|2019|Fukuda K,Date H,Doi S,Fukumoto Y,Fukushima N,|therapy,

Home Oxygen Therapy for Children. An Official American Thoracic Society Clinical Practice Guideline
https://www.atsjournals.org/doi/full/10.1164/rccm.201812-2276ST
Hayes,D.,et al

Jan 31st, 2019 - Although home oxygen therapy is commonly required in the care of children, there is a striking lack of empirical evidence regarding implementation, monitoring, and discontinuation of supplemental oxygen therapy. The panel formulated and provided t...

see more →

Drugs  7 results see all →

Clinicaltrials.gov  18,443 results

Recent advances in the management of pulmonary arterial hypertension: lessons from the ...
https://doi.org/10.1080/17476348.2021.1878027
Expert Review of Respiratory Medicine; Escribano Subías P, Aurtenetxe Pérez A et. al.

Jan 21st, 2021 - The 6th World Symposium of Pulmonary Hypertension (6th WSPH) brought to the forefront for the first time the value of earlier, aggressive management with an upfront oral combination in patients with pulmonary arterial hypertension (PAH) of low or ...

Comparison of 68Ga-FAPI imaging and cardiac magnetic resonance in detection of myocardi...
https://doi.org/10.1007/s12350-020-02517-2 10.1007/s12350-020-02315-w 10.1007/s12350-020-02407-7 10.1161/CIRCULATIONAHA.118.035326 10.1016/j.jcmg.2019.06.030 10.1007/s00330-016-4585-y
Journal of Nuclear Cardiology : Official Publication of T... Xing HQ, Gong JN et. al.

Jan 21st, 2021 - Comparison of 68Ga-FAPI imaging and cardiac magnetic resonance in detection of myocardial fibrosis in a patient with chronic thromboembolic pulmonary hypertension.|2021|Xing HQ,Gong JN,Chen BX,Guo XJ,Yang YH,|

Bevacizumab combined with pemetrexed successfully treated lung adenocarcinoma complicat...
https://doi.org/10.21037/apm-20-2220
Annals of Palliative Medicine; Lu L, Wang Z et. al.

Jan 21st, 2021 - Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare but severe pulmonary complication of malignant tumors. It is characterized by the presence of multiple microscopic tumor emboli attached to the endothelium of small pulmonary arteries and...

The prevalence and clinical outcome of supraventricular tachycardia in different etiolo...
https://doi.org/10.1371/journal.pone.0245752
PloS One; Fingrova Z, Ambroz D et. al.

Jan 20th, 2021 - Patients with pulmonary hypertension (PH) frequently suffer from supraventricular tachycardias (SVT). The main purpose of our study was to identify the cumulative incidence of SVT in patients with different etiologies of PH. The secondary objectiv...

see more →

News  567 results

Inhaled Treprostinil Improves Walking Distance in Patients With Pulmonary Hypertension
https://www.medscape.com/viewarticle/944054

Jan 13th, 2021 - NEW YORK (Reuters Health) - Frequent daily inhalation treatment with the United Therapeutics drug treprostinil significantly increased the six-minute walking distance of people whose interstitial lung disease left them with pulmonary hypertension,...

Under Pressure: An Update on Pulmonary Hypertension
https://www.the-rheumatologist.org/article/under-pressure-an-update-on-pulmonary-hypertension/
The Rheumatologist; Liebowitz J.

Nov 8th, 2020 - In patients with connective tissue diseases, such as systemic sclerosis (SSc), pulmonary hypertension (PH) remains one of the leading causes of morbidity and mortality. In her lecture on Friday, Nov. 6, Pulmonary Hypertension: An Update, Mardi Gom...

Levosimendan Hints at Potential Benefit in Unusual Form of Heart Failure
https://www.staging.medscape.com/viewarticle/938671

Oct 5th, 2020 - An inotropic and vasodilating drug with few clinical-trial victories in heart failure (HF) or other low-cardiac-output conditions showed some limited success in a specific subtype of HF with preserved ejection fraction (HFpEF). Patients with pulmo...

Levosimendan Hints at Potential Benefit in Unusual Form of Heart Failure
https://www.medscape.com/viewarticle/938671

Oct 5th, 2020 - An inotropic and vasodilating drug with few clinical-trial victories in heart failure (HF) or other low-cardiac-output conditions showed some limited success in a specific subtype of HF with preserved ejection fraction (HFpEF). Patients with pulmo...

Treprostinil Improves Walk Distance in Pulmonary Hypertension
https://www.medscape.com/viewarticle/933674

Jul 8th, 2020 - Patients with interstitial lung disease–associated pulmonary hypertension who were treated with inhaled treprostinil (Tyvaso) had significantly greater improvement in exercise capacity over 16 weeks, compared with patients who used a placebo inhal...

see more →

Patient Education  41 results see all →